Abstract: Background: Opioid analgesics are commonly used along with propofol during general anesthesia. Due to the dearth of data on the quality of anesthesia achieved with this combination, the present meta-analysis was carried out.
INTRODUCTION
Propofol is a general anesthetic drug widely used for daycare surgeries with the advantages of faster onset and shorter duration of anesthesia [1] . The main drawback associated with the administration of propofol alone is the injectionrelated pain reported in nearly 60% and even slightly more (85%) in children [2, 3] . Other adverse events related to propofol include systemic hypotension, allergy, hypertriglyceridemia and pancreatitis [4] .
Fentanyl is a potent synthetic opioid analgesic used in combination with other drugs for producing balanced general *Address correspondence to this author at the Department of Pharmacology & Therapeutics, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain; Tel: +973-33453123; E-mail: skannandr@gmail.com anesthesia [5] . The main attributes of fentanyl are pain relief and sedation that are equally applicable to other drugs in the series such as remifentanil, alfentanil and sufentanil. Studies have shown that the combination of opioid analgesics with propofol decreases the incidence of propofol related pain as well as the severity [6] . Interestingly, the addition of propofol also decreases the incidence of fentanyl-induced cough [7] . Remifentanil is a highly potent opioid drug with the fastest onset of action (of about one minute) and a shorter elimination half-life of 10 minutes [8] . Similar activity has been observed with alfentanil and sufentanil [9] . Amidst the studies comparing pharmacodynamic effects of the above opioids, there is a dearth of data regarding the onset, duration and the extent of general anesthesia attained with the combination of opioid analgesics and propofol. Hence, we undertook the systematic review and meta-analysis to compare the profile of general anesthesia of remifentanil, sufentanil and alfentanil with fentanyl when combined with propofol.
METHODS

Information Sources and Search Strategy
The protocol for this review was registered with the International prospective register of systematic reviews (PROSPERO) with the registration number CRD 42016045622. The review protocol can be accessed at http://www.crd.york.ac.uk/PROSPERO/display_record.asp?I D=CRD42016045622. A thorough literature search was conducted and was completed on 14 August 2016. The primary database used was Medline (via PubMed), Cochrane central register of clinical trials (CENTRAL), Database of Abstracts of Reviews of Effects (DARE) and Google Scholar. The keywords used were Propofol [tiab] AND fentanyl [tiab] . This search was further supplemented by manual searching of relevant references from review articles and other eligible studies. We did not pose any limitation to any language or date in the present study.
Eligibility Criteria
Studies with randomized controlled design meeting the following requirements were included in the present study:
1. Type of participants-Any patient undergoing surgery or endoscopy under general anesthesia.
2. Type of intervention-A combination of either remifentanil or sufentanil or alfentanil with propofol.
3. Comparison-Combination of fentanyl and propofol.
4. Outcome-Total dose of propofol required to achieve the desired general anesthesia, time of onset and duration of general anesthesia, depth of general anesthesia and recovery time (time for eye-opening and time taken for extubation).
Study Procedure
Two authors independently screened the databases and reviewed the identified abstracts for suitability. Full-text articles were obtained following abstract screening for those found to be eligible to be included in the review. A pretested data extraction form was created and both the authors independently extracted the following data from each of the eligible studies as follows: trial site, year, trial methods, participants, interventions, and outcomes. Disagreement between the authors was resolved through discussion. The extracted data were analyzed using non-Cochrane mode in RevMan 5.3 software. The methodological quality of the trials was assessed using The Cochrane collaboration's tool for assessing the risk of bias across the following six domains: sequence generation, allocation concealment, blinding (of participants, personnel, and outcome assessors), incomplete outcome data, selective outcome reporting, and other sources of bias. The judgment was categorized into the low, high or unclear risk of bias [8] . For continuous outcome measures, mean differences (MD) were considered for the final assessment from individual studies with 95% confidence interval (95% CI) as a measure to represent the deviation from the point estimate. Heterogeneity between the studies was assessed using Forest plot visually, I
2 statistics wherein more than 30% was considered to have moderate to severe heterogeneity and Chi-square test with a statistical Pvalue of less than 0.10 to indicate statistical significance. Random-effect models were chosen in cases of moderate to severe heterogeneity otherwise, fixed-effect models were used. The present meta-analysis was conducted and presented in compliance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [9] .
RESULTS
Search Results
A total of 2879 articles were obtained, of which 14 studies [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] were found eligible to be included in the systematic review (Fig. 1) . Except one [10] , all were also included in the meta-analysis. The key characteristics of the included studies are mentioned in Table 1 . A summary of the risk of bias of the included studies is depicted in Fig. (2) .
Pooled Results
Total Propofol Dose
Seven studies (284 participants) assessed the dose (in mg) of propofol required to achieve general anesthesia. The pooled estimate {mean difference of -76.18 [-94.72, -57 .64]} favored the combination of remifentanil than fentanyl when combined with propofol (Fig. 3) . Similarly, three studies (340 participants) compared the total propofol dose required with alfentanil and fentanyl; and two studies (85 participants) compared the same between sufentanil and fentanyl groups. No significant differences were observed with the pooled estimates for either alfentanil {-6.32 [-13.23, 0.60]} or sufentanil {-4.01 [-9 .85, 1.84]} when combined with propofol.
Time for Induction of Anesthesia
Three studies (94 patients) compared the induction time for anesthesia when remifentanil was combined with propofol to fentanyl. The pooled estimate was found to favor remifentanil {-0.44 [-0.74, -0.15]} (Fig. 4) . There were no studies comparing the induction time for alfentanil or sufentanil when combined with propofol.
Duration of Anesthesia
Three studies (110 patients) compared the duration of anesthesia (in minutes) for remifentanil compared to fentanyl when combined with propofol. The pooled estimate was not found to be significantly different between the groups {2.37 [-2.52, 7.25]}. Only one study compared the duration of anesthesia with alfentanil and sufentanil and hence pooling of the results was not attempted.
Time Taken for Eye-opening
Three studies (120 participants) compared the time taken for eye-opening (in minutes) when remifentanil was combined with propofol compared to fentanyl and propofol. The pooled estimate was observed to favor remifentanil with the mean difference [95% confidence interval] of -3.95 [-4.8, -3.1] (Fig. 5) . Two studies (300 patients) compared the time taken for awakening when alfentanil was combined with propofol compared to fentanyl and propofol combination but the pooled estimate was not found to be statistically significant {-0.27 [-0.89, 0.34]}. Unfortunately, only one study compared this outcome parameter for sufentanil and so data pooling was not attempted.
Time for Extubation
Three studies (120 patients) compared the time taken for extubation for remifentanil and fentanyl. The pooled mean difference [95% confidence interval] was -3.53 [-4.37, -2.7] favoring remifentanil (Fig. 6) . Only one study compared the time for extubation for alfentanil and sufentanil and so pooling of the results was not attempted.
Bispectral Index
Two studies (67 patients) compared the bispectral index when remifentanil was combined with propofol to fentanyl combination and the pooled estimate was not statistically significant {1.69 [-0.28, 3 .65]}. Only one study compared the bispectral index with alfentanil and sufentanil and hence no pooling of the results was not attempted.
DISCUSSION
We conducted the present study to assess the profile of general anesthesia with remifentanil, sufentanil and alfentanil when combined with propofol and compared to fentanyl with propofol combination. A total of 14 studies were included in this review, and we observed that when remifentanil was combined with propofol, a significantly low dose of propofol was required to achieve general anesthesia. Moerover,the duration, onset and depth of general anesthesia were significantly more compared to fentanyl combination.
Combination of opioid analgesic with propofol has been shown to be an effective and safe method of analgosedation for patients undergoing mechanical ventilation [24] . Propofol has also been shown to be a better general anesthetic agent for successful insertion of laryngeal mask airway as it sufficiently suppresses the laryngeal reflexes leading to minimal coughing, gagging, and laryngospasm [25] . However, the incidence of pain following propofol administration is a major disadvantage, reducing the quality of anesthesia. The combination of opioid analgesics with propofol has been shown to prevent pain with a number needed to treat (NNT) of 3 to 4 in comparison to lidocaine where NNT was found to be 2.4 [26] . Combination of opioids with propofol has also been shown to improve the success of laryngeal mask airway insertion [27] . Additionally, the combination of propofol with fentanyl has been shown to decrease the incidence of fentanyl-induced cough more than lidocaine and NMDAreceptor antagonists in a meta-analysis [28]. Weisenberg et al. have observed a 31% increase in the mean number of hypotensive or bradycardia episodes requiring interventions with an increase of 0.3 mg/kg dose of propofol [25] . Combining an opioid analgesic lowers the total dose of propofol that is required, thereby reducing the risk of propofolinduced cardiac adverse events. We also found that the dose of propofol required to produce general anesthesia is significantly lower with remifentanil than fentanyl. In addition to duration, remifentanil also has a faster onset and recovery of (3) . Forest plot of total propofol dose (mg) required to achieve general anesthesia when combined with either remifentanil and fentanyl. A statistically significant decrease in the required total dose of propofol was observed with remifentanil than fentanyl to achieve general anesthesia. (A higher resolution / colour version of this figure is available in the electronic copy of the article). anesthesia when compared to fentanyl. Other favorable pharmacological aspects of remifentanil include minimal alteration of the pharmacokinetics, in patients with extremes of age or renal or hepatic dysfunction and ease of drug administration and titration [29] . Similarly, Kawano et al. [30] have also shown that co-administration of remifentanil reduces the intra-operative blood loss significantly than fentanyl. effectiveness data of the combination of opioid analgesics with propofol is lacking.
The strength of this review is that this is the first systematic compilation and pooled analysis of the existing literature regarding the use of opioids as adjuvants with propofol for obtaining general anesthesia. However, the review was also limited by the following: our search databases did not include EMBASE due to access constraints; dose variations in the propofol and individual opioids were not accounted for; due to paucity in the total number of studies with alfentanil and sufentanil, valid estimates could not be obtained; and most of the included studies had a high risk of bias in at least one of the domains.
CONCLUSION
To conclude, we found that remifentanil has a statistically significant anesthetic profile than fentanyl when combined with propofol. Scanty evidence for both alfentanil and sufentanil precludes any such confirmation.
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